Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
This trial studies patients with coronary artery disease who have undergone imaging-guided implantation of drug-eluting stents DES. It compares the safety of a tailored antiplatelet therapy strategyshort dual antiplatelet therapy DAPT followed by P2Y12 inhibitor aloneto the conventional longer DAPT approach. The goal is to see if the tailored strategy reduces bleeding without increasing risks of ischemic events after optimized stent placement guided by intravascular ultrasound IVUS or optical coherence tomography OCT. Participants are randomly assigned to one of two groups the conventional arm receiving 12 months of DAPT aspirin plus clopidogrel for chronic coronary syndrome or aspirin plus ticagrelorprasugrel for acute coronary syndrome, and the tailored arm receiving a shorter DAPT duration 1 month for chronic coronary syndrome or 3 months for acute coronary syndrome followed by P2Y12 inhibitor alone. All stent implantations are optimized by intravascular imaging. Clinical follow-up visits occur at 1 or 3, 6, 12, 18, 24, 36, 48, and 50 months after the procedure. Participants will undergo clinical assessments to monitor ischemic events such as death, heart attack, repeat procedures, and stent thrombosis, as well as bleeding events categorized by standard criteria, all measured at 12 months. Additional evaluations include cardiovascular death, stroke, and stent coverage by OCT in a substudy. Safety and effectiveness endpoints will be analyzed primarily by intention-to-treat. The total study duration extends up to about 50 months with multiple follow-up visits to assess long-term outcomes.